Company / AR per Share
BioLife Solutions, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.16
FY2025
5-year range
$0.16 / $0.79
FY2021-FY2025
Trend
-11.1%
vs FY2024
Sector context
#133 of 141
Health Care
What the data says
Among 141 Health Care companies, BioLife Solutions, Inc. is in the bottom 6% for ar per share. AR per Share has fluctuated over the past 10 years, ranging from $0.07 in FY2018 to $0.79 in FY2022.
Based on SEC 10-K filings.
0.16 in FY2025 with a 5-year CAGR of -11.0%.
Declined from $0.18 to $0.16 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -40.8%
- 5-Year CAGR
- -11.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 141This company $0.16 Sector average $11.78
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 11.1% year-over-year.
- Ranks #133 out of 141 companies in the Health Care sector.
- Peak ar per share was recorded in FY2022.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.16 | -11.1% |
| FY2024 | $0.18 | +1.8% |
| FY2023 | $0.18 | -77.1% |
| FY2022 | $0.79 | +30.7% |
| FY2021 | $0.60 | +105.7% |
| FY2020 | $0.29 | +6.7% |
| FY2019 | $0.27 | +285.6% |
| FY2018 | $0.07 | -10.3% |
| FY2017 | $0.08 | -17.2% |
| FY2016 | $0.10 | +24.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026